Delivery Order SPE2DB20D2104-SPE2DB24FU83E
Award Date
6/24/24
Potential Completion Date
6/25/24
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Gardasil 9 syringes, a vaccine for the prevention of certain types of human papillomavirus. The contract is a firm-fixed-price delivery order with a ceiling value of $3,494.92 and a period of performance through January 30, 2025. The contract is not designated as a set-aside. AmerisourceBergen...
This is a $21,088.73 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Gardasil 9, a vaccine for the prevention of certain types of human papillomavirus (HPV), with an ultimate completion date of July 31, 2024. The award is not associated with a set-aside program. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 vaccine syringes, a pharmaceutical product used to prevent certain types of human papillomavirus (HPV) infections. The contract has a ceiling value of $20,339.98 and is a firm fixed-price contract with an ultimate completion date of September 19, 2024. Amerisourcebergen, a major...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,902.47 firm-fixed-price contract is for the delivery of GARDASIL 9 syringes, a human papillomavirus vaccine, to support military healthcare programs. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,565.62 firm fixed-price contract is for the delivery of Gardasil 9 vaccine syringes. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded to Amerisourcebergen Drug Corp under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,565,179 units of the GARDASIL 9 vaccine, a pharmaceutical product used to prevent certain types of human papillomavirus (HPV) infections. The delivery order has a ceiling value of $8,857.24 and a firm fixed-price pricing structure. It has a period of performance through July 18, 2024. This contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The $32,335.60 firm-fixed-price contract has an ultimate completion date of August 23, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $3,163.03 and an ultimate completion date of November 22, 2023. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The firm-fixed-price contract has a ceiling value of $10,074.63 and is set to expire on July 31, 2024. Amerisourcebergen will be providing the GARDASIL 9 vaccine syringes, which are used to deliver the immunization against certain types of human papillomavirus. This contract is not designated as a set-aside...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GARDASIL 9 vaccine syringes. The $10,451.96 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA...